STC-15 is well tolerated and demonstrates promising signs of clinical activity observed in multiple tumor types Gene expression data shows upregulation of innate immunity pathways Tumor regressions ...
Mr. Kyei joins after more than a decade at Jefferies, where he was most recently a Managing Director in its Technology Group, leading the company’s education technology and tech-enabled services ...